Inhibin A measurement using an automated assay platform

Prenatal Diagnosis

Volumn 28, Issue 5, 2008, Pages 399-403

  Lambert Messerlian, G M ^a,b   Palomaki, G E ^a   Canick, J A ^a  

^a BROWN UNIVERSITY   (United States)

^b WOMEN AND INFANTS HOSPITAL   (United States)

Author keywords

Automation; Down syndrome; Inhibin A; Pregnancy; Screening

Indexed keywords

INHIBIN A;

ARTICLE; AUTOMATED ASSAY; CONFIDENCE INTERVAL; DOWN SYNDROME; ENZYME ASSAY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MATERNAL SERUM; NORMAL DISTRIBUTION; PREGNANCY; PRIORITY JOURNAL; SCREENING;

BLOOD CHEMICAL ANALYSIS; DOWN SYNDROME; FEMALE; HUMANS; INHIBINS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS;

EID: 45249121816     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1983     Document Type: Article

References (14)

1. Aitken DA, Wallace EM, Crossley JA, et al. 1996. Dimeric inhibin A as a marker for Down's syndrome and trisomy 18 pregnancies at 7-18 weeks' gestation. N Engl J Med 334: 1231-1236.
2. Bland JM, Altman DG. 1986. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet i: 301-310.
3. Cuckle HS, Holding S, Jones R, Groome NP, Wallace EM. 1996. Combining inhibin A with existing second-trimester markers in maternal serum screening for Down's syndrome. Prenat Diagn 16: 1095-1100.
4. Erickson JA, Ashwood ER, Gin CA. 2004. Evaluation of a dimeric inhibin-A assay for assessing fetal Down syndrome: establishment, comparison, and monitoring of median concentrations for normal pregnancies. Arch Pathol Lab Med 128: 415-420.
5. Haddow JE, Palomaki GE, Knight GJ, Foster DL, Neveux LM. 1998. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A. J Med Screen 5: 115-119.
6. Knight GJ, Palomaki GE, Neveux LM, Haddow JE, Lambert-Messerlian GM. 2001. Clinical validation of a new dimeric inhibin-A assay suitable for second trimester Down's syndrome screening. J Med Screen 8: 2-7.
7. Lambert-Messerlian GM, Canick JA, Palomkai GE, Schneyer AL. 1996. Second trimester levels of maternal serum inhibin A, total inhibin, alpha inhibin precursor, and activin in Down's syndrome pregnancy. J Med Screen 3: 58-62.
8. Malone FD, Canick JA, Ball RH, et al. 2005. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 353: 2001-2011.
9. NCCLS Approved Guideline Second Addition EP5-A2. 2004. Evaluation of Precision Performance of Quantitative Measurement Methods. National Committee for Clinical Laboratory Standards: Wayne, PA.
10. Spencer K, Wallace EM, Ritoe S. 1996. Second-trimester dimeric inhibin-A in Down's syndrome screening. Prenat Diagn 16: 1101-1110.
11. Wald NJ, Kennard A, Hackshaw A, McGuire A. 1997. Antenatal screening for Down's syndrome. J Med Screen 4: 181-246.
12. Wald NJ, Densem JW, George L, Muttukrishna S, Knight PG. 1996. Prenatal screening for Down's syndrome using inhibin-A as a serum marker. Prenat Diagn 16: 143-153.
13. Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. 2003. First and second trimester antenatal screening for Down's syndrome: the results of the serum, urine and ultrasound screening study (SURUSS). J Med Screen 10: 56-104.
14. Wallace EM, Swanston IA, McNeilly AS, et al. 1996. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A. Clin Endocrinol 44: 17-21.